Our results suggest that FLX treatment induces dematuration of the FC and hippocampus of adult mice with respect to genome-wide gene expression patterns. The dematuration of these brain regions might be involved in the therapeutic mechanism of FLX and/or some of its adverse effects. 
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The role of Toxoplasma gondii in depression and anxiety -gene-environment interactions in the FSL rat model
Cecilie Bay-Richter, Eskild Petersen, Gregers Wegener Aarhus University, Denmark
Abstract Toxoplasma gondii (TOX) is a common parasite affecting approximately one-third of the human population. An increasing number of studies are providing evidence that the disease is associated with behavioural changes and psychiatric disease. Using the Flinders Sensitive-Line (FSL) rat model, the objective of the current study was to characterize TOX-induced behavioural changes and whether the behavioural outcome is affected by genetic vulnerability. Rats were infected p.o. with 20 TOX-cysts. Twelve weeks postinfection, the animals were subjected to a behavioural test-battery including tests for depression (sucrose-preference test (SPT) and forced-swim test (FST)) and anxiety (elevated plus-maze (EPM) and light-dark box (LDB)).
In the LDB TOX-infected animals, independent of phenotype, spent less time in the light area (p<0.05). In the EPM a strain effect was found, with FSL animals spending less time in the open arms compared to their FRL controls (p=0.01). Furthermore, a strain X treatment interaction was found; when treated with TOX, FRL animals spent as little time in the open arms as the FSL animals (p=0.01). In the SPT an interaction between strain and treatment was also found; vehicle treated FSL animals did not show anhedonia when compared to FRL animals, whereas TOX treated FSL, but not FRL, animals displayed a marked decrease in sucrose consumption (p=0.010). A similar interaction is found in the FST where FSL, but not FRL, animals displayed increased despair following TOX treatment (P<0.05).
These data show that TOX can induce anxiety-like behaviour in rats independent of phenotype. Furthermore, we find that genetically vulnerable FSL animals display more severe depressive-like symptoms following TOX infection. Such results are in line with clinical studies showing a marked increase of toxoplasmosis in anxiety patients compared to healthy controls and moreover suggest an interplay between gene and environment leaving genetically vulnerable subjects susceptible to depression induced by chronic toxoplasmosis.
PS134
A strategy for treating in deficits of social behaviors induced by exposure to social defeat stress as juveniles 
The persistent deficits of social behaviors in mice exposed to social defeat stress as juveniles are useful for studying the pathogenesis of psychiatric disorders following the adverse childhood experiences. In the present study, we investigated a strategy for treating in deficits of social behaviors induced by exposure to social defeat stress as juveniles. Methods: The juvenile male C57BL/6J mice were exposed to a male aggressive ICR mouse during 1 or 10 consecutive days. Mice were acutely administered desipramine (a noradrenaline reuptake inhibitor), sertraline (a selective serotonin reuptake inhibitor), aripiprazole (a dopamine receptor partial agonist), and memantine [a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist] on 1 day after the last exposure to social defeat stress. Administration of desipramine, sertraline, and aripiprazole were also continued once a day for 15 days. We assessed social behaviors at 1 and 15 days after the last exposure to the stress. Monoamine turnover and phosphorylation of NMDA receptor subunits were determined in some brain regions of mice exposed to the stress. Results: Acute and repeated administration of desipramine, sertraline, and aripiprazole did not attenuate deficits of social behaviors in mice exposed to stress as juveniles. Co-administration of aripiprazole with sertraline repeatedly and administration of memantine acutely showed a tendency and significant, respectively, to attenuate deficits of social behaviors. Utilization of serotonin/dopamine and the phosphorylated protein levels of NR2A were decreased and increased, respectively, in some brain regions of mice showing deficits of social behaviors. Conclusion: These findings suggest that social defeat stress as juveniles induces the development of antidepressant-treatmentresistant deficits of social behaviors related to monoaminergic and/or glutamatergic dysfunction. Serotonergic and dopaminergic activators or glutamatergic inhibitors may be a strategy for treating to attenuate the treatment-resistant deficits.
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Effects of the mineralocorticoid receptor antagonist spironolactone in a treatment-resistant model of depression in female rats 
Abstract
In recent studies we have shown that the tryptophan (TRP) depletion model of depression previously validated in male rats is paroxetine-resistant in females (Franklin et al. 2015) . In this model, we found that secretion of the mineralocorticoid hormone aldosterone increased after 4 days of TRP depletion and surprisingly prior to corticosterone enhancement. The study aim was to investigate the effects of mineralocorticoid receptor (MR) blockade on depression-like behaviour induced by TRP depletion.
Female rats were fed a control (0.2% of TRP) or low TRP diet (0.04% of TRP) for 14 days. They were simultaneously treated with the MR antagonist spironolactone (1.2 mg/rat/day) or placebo via matrix-driven delivery pellets (Innovative Research of America, USA) for 14 days. Rats were tested in the Forced Swim Test (FST) on treatment day 14. Animals were sacrificed by decapitation on day 15. Two-way ANOVA showed that TRP depletion resulted in an increased immobility time in the FST. Further analysis showed that TRP-depleted rats treated with spironolactone but with placebo spent a significantly shorter time immobile compared to controls. Rats exposed to TRP depletion exhibited significantly higher serum concentrations of aldosterone and corticosterone, which were slightly modified by spironolactone treatment. TRP depletion significantly enhanced serum interleukin-6 as well as gene expression of orexin A, a neuropeptide related to ghrelin, which has been shown to be altered in patients with treatmentresistant depression.
Findings show that treatment of rats with the MR antagonist spironolactone results in a mild improvement of TRP depletioninduced depression-like behaviour. Blockade of aldosterone action could represent a target for new antidepressant treatment.
This study was supported by grant of VEGA 2 /0128/14, Oxford, UK) . Franklin et al., Neuroendocrinology, 102(4):274-287, 2015 .
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Time-dependent alteration of reward-induced dopamine release in the nucleus accumbens of the neuropathic pain model rats.
